Clinical Laserthermia Systems AB (publ) announced that the company's acting CEO Dan J. Mogren returns to work from April 1st, after a planned medical leave from February 10th until March 31st. Dan J. Mogren replaces deputy CEO Lars-Erik Eriksson, who will continue his role as CFO.
Clinical Laserthermia Systems AB
Equities
CLS B
SE0022049920
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.93 SEK | +2.24% |
|
0.00% | -78.51% |
05-31 | Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue | MT |
05-29 | Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.51% | 4.37M | |
-3.54% | 798M | |
-29.85% | 223M | |
0.00% | 142M | |
-36.21% | 73.65M | |
+8.18% | 57.61M |
- Stock Market
- Equities
- CLS B Stock
- News Clinical Laserthermia Systems AB
- Clinical Laserthermia Systems AB Announces CEO Changes